These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 18064299

  • 1. Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells.
    Moutouh-de Parseval LA, Verhelle D, Glezer E, Jensen-Pergakes K, Ferguson GD, Corral LG, Morris CL, Muller G, Brady H, Chan K.
    J Clin Invest; 2008 Jan; 118(1):248-58. PubMed ID: 18064299
    [Abstract] [Full Text] [Related]

  • 2. Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice.
    Meiler SE, Wade M, Kutlar F, Yerigenahally SD, Xue Y, Moutouh-de Parseval LA, Corral LG, Swerdlow PS, Kutlar A.
    Blood; 2011 Jul 28; 118(4):1109-12. PubMed ID: 21536862
    [Abstract] [Full Text] [Related]

  • 3. Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture.
    Watanapokasin R, Sanmund D, Winichagoon P, Muta K, Fucharoen S.
    Ann Hematol; 2006 Mar 28; 85(3):164-9. PubMed ID: 16389564
    [Abstract] [Full Text] [Related]

  • 4. Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease.
    Cui S, Engel JD.
    Adv Exp Med Biol; 2017 Mar 28; 1013():177-202. PubMed ID: 29127681
    [Abstract] [Full Text] [Related]

  • 5. Understanding heterogeneity of fetal hemoglobin induction through comparative analysis of F and A erythroblasts.
    Khandros E, Huang P, Peslak SA, Sharma M, Abdulmalik O, Giardine BM, Zhang Z, Keller CA, Hardison RC, Blobel GA.
    Blood; 2020 May 28; 135(22):1957-1968. PubMed ID: 32268371
    [Abstract] [Full Text] [Related]

  • 6. High-level induction of fetal haemoglobin by pomalidomide in β-thalassaemia/HbE erythroid progenitor cells.
    Khamphikham P, Nualkaew T, Pongpaksupasin P, Kaewsakulthong W, Songdej D, Paiboonsukwong K, Engel JD, Hongeng S, Fucharoen S, Sripichai O, Jearawiriyapaisarn N.
    Br J Haematol; 2020 Jun 28; 189(6):e240-e245. PubMed ID: 32358840
    [No Abstract] [Full Text] [Related]

  • 7. Influence of hydroxyurea on fetal hemoglobin production in vitro.
    Miller BA, Platt O, Hope S, Dover G, Nathan DG.
    Blood; 1987 Dec 28; 70(6):1824-9. PubMed ID: 2445401
    [Abstract] [Full Text] [Related]

  • 8. Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or beta-thalassemia.
    Fibach E, Burke LP, Schechter AN, Noguchi CT, Rodgers GP.
    Blood; 1993 Mar 15; 81(6):1630-5. PubMed ID: 7680923
    [Abstract] [Full Text] [Related]

  • 9. Hydroxyurea therapy in thalassemia.
    Loukopoulos D, Voskaridou E, Stamoulakatou A, Papassotiriou Y, Kalotychou V, Loutradi A, Cozma G, Tsiarta H, Pavlides N.
    Ann N Y Acad Sci; 1998 Jun 30; 850():120-8. PubMed ID: 9668534
    [Abstract] [Full Text] [Related]

  • 10. Pomalidomide reverses γ-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors.
    Dulmovits BM, Appiah-Kubi AO, Papoin J, Hale J, He M, Al-Abed Y, Didier S, Gould M, Husain-Krautter S, Singh SA, Chan KW, Vlachos A, Allen SL, Taylor N, Marambaud P, An X, Gallagher PG, Mohandas N, Lipton JM, Liu JM, Blanc L.
    Blood; 2016 Mar 17; 127(11):1481-92. PubMed ID: 26679864
    [Abstract] [Full Text] [Related]

  • 11. Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells.
    Keefer JR, Schneidereith TA, Mays A, Purvis SH, Dover GJ, Smith KD.
    Exp Hematol; 2006 Sep 17; 34(9):1151-61. PubMed ID: 16939808
    [Abstract] [Full Text] [Related]

  • 12. Thiourea derivatives induce fetal hemoglobin production in-vitro: A new class of potential therapeutic agents for β-thalassemia.
    Ali H, Iftikhar F, Shafi S, Siddiqui H, Khan IA, Choudhary MI, Musharraf SG.
    Eur J Pharmacol; 2019 Jul 15; 855():285-293. PubMed ID: 31100414
    [Abstract] [Full Text] [Related]

  • 13. A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger.
    Mabaera R, West RJ, Conine SJ, Macari ER, Boyd CD, Engman CA, Lowrey CH.
    Exp Hematol; 2008 Sep 15; 36(9):1057-72. PubMed ID: 18718415
    [Abstract] [Full Text] [Related]

  • 14. BFU-E colony growth in response to hydroxyurea: correlation between in vitro and in vivo fetal hemoglobin induction.
    Yang YM, Pace B, Kitchens D, Ballas SK, Shah A, Baliga BS.
    Am J Hematol; 1997 Dec 15; 56(4):252-8. PubMed ID: 9395188
    [Abstract] [Full Text] [Related]

  • 15. Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers.
    Breda L, Motta I, Lourenco S, Gemmo C, Deng W, Rupon JW, Abdulmalik OY, Manwani D, Blobel GA, Rivella S.
    Blood; 2016 Aug 25; 128(8):1139-43. PubMed ID: 27405777
    [Abstract] [Full Text] [Related]

  • 16. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.
    Zhang Y, Paikari A, Sumazin P, Ginter Summarell CC, Crosby JR, Boerwinkle E, Weiss MJ, Sheehan VA.
    Blood; 2018 Jul 19; 132(3):321-333. PubMed ID: 29884740
    [Abstract] [Full Text] [Related]

  • 17. Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and beta-thalassemia.
    Fibach E, Prasanna P, Rodgers GP, Samid D.
    Blood; 1993 Oct 01; 82(7):2203-9. PubMed ID: 7691251
    [Abstract] [Full Text] [Related]

  • 18. Monoterpenes as therapeutic candidates to induce fetal hemoglobin synthesis and up-regulation of gamma-globin gene: An in vitro and in vivo investigation.
    Iftikhar F, Khan MBN, Musharraf SG.
    Eur J Pharmacol; 2021 Jan 15; 891():173700. PubMed ID: 33137331
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and pharmacological evaluation of pomalidomide derivatives useful for sickle cell disease treatment.
    de Melo TRF, Dulmovits BM, Fernandes GFDS, de Souza CM, Lanaro C, He M, Al Abed Y, Chung MC, Blanc L, Costa FF, Dos Santos JL.
    Bioorg Chem; 2021 Sep 15; 114():105077. PubMed ID: 34130111
    [Abstract] [Full Text] [Related]

  • 20. HRI depletion cooperates with pharmacologic inducers to elevate fetal hemoglobin and reduce sickle cell formation.
    Peslak SA, Khandros E, Huang P, Lan X, Geronimo CL, Grevet JD, Abdulmalik O, Zhang Z, Giardine BM, Keller CA, Shi J, Hardison RC, Blobel GA.
    Blood Adv; 2020 Sep 22; 4(18):4560-4572. PubMed ID: 32956454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.